Mirati Therapeutics OverviewMirati Therapeutics Net Income
Profitability analysis for MRTX.
Quarterly Net Income
-$161.90M
↑ 6.72% YoY
As of Sep 2023
Annual Net Income (TTM)
-$716.64M
↑ 2.9% YoY
Trailing 12 months ending Sep 2023
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...